Acceptability of Norplant® at a well-woman clinic in turkey

European Journal of Contraception and Reproductive Health Care

Volumn 5, Issue 2, 2000, Pages 119-123

  Ortayli, N ^a,b   Amca, B ^a   Say, L ^a   Bulut, A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Acceptability; Continuation rates; Cost estimation; Hormonal contraceptive implant; Norplant; Turkey

Indexed keywords

LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; COST BENEFIT ANALYSIS; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; TURKEY (REPUBLIC); DRUG IMPLANT; ECONOMICS; LIFE TABLE; PATIENT ATTITUDE; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; CONTRACEPTIVES, ORAL, SYNTHETIC; COST-BENEFIT ANALYSIS; DRUG IMPLANTS; FEMALE; HUMANS; LEVONORGESTREL; LIFE TABLES; LOGISTIC MODELS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TURKEY;

EID: 0033624590     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/13625180008500382     Document Type: Article

References (10)

1. 1. Fraser IS, Tiitinen A, Affandi A, et al. Norplant® consensus statement and background review. Contraception 1998;57:1-9
2. 2. Vekemans M, Delvigne A, Paesmans M. Continuation rates with a levonorgestrel-releasing contraceptive implant (Norplant®). Contraception 1997;56:291-9
3. 3. Hacettepe University, Institute of Population Studies, Macro International and United Nations Population Fund (UNFPA), Turkish Demographic and Health Survey, 1998, Ankara, Turkey: Hacettepe University, Institute of Population Studies, 1999
4. 4. Su-Juan G, Ming-Kun D, Ling-De Z, Ying-Lin L, Shu-Hua W, Sivin I. A 5-year evaluation of Norplant® contraceptive implants in China. Obstet Cynecol 1994; 83:673-8
5. 5. Say L, Ortayli N, Nalbant H. Women's acceptance of injectable progestin-only contraceptive in a free-choice environment in Turkey. In van Lunsen RHW, Unzeitig V, Creatsas G, eds. Contraceptive Choices and Realities. Carnforth, UK: Parthenon Publishing, 2000:140-2
6. 6. Trussel J, Leveque JA, Koenig JD, et al. The economic value of contraception: a comparison of 15 methods. Am J Public Health 1995;85:494-503
7. 7. Croxatto HB, Mäkäräinen L. The pharmacodynamics and efficacy of Implanon®. Contraception 1998;58: 91S-7S
8. 8. Affandi D. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon®. Contraception 1998;58:99S-107S
9. 9. Mascaranhas L. Insertion and removal of Implanon®. Contraception 1998;58:79S-83S
10. 10. Zeng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon®) and a six-capsule (Norplant®) hormonal contraceptive implant. Contraception 1999;60:1-8